Human recombinant ACE2 reduces the progression of diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

http://www.wikidata.org/entity/Q41786103

about

Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus.Classical Renin-Angiotensin system in kidney physiology Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.Nonclassical renin-angiotensin system and renal function.ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.Inflammation in the pathogenesis of microvascular complications in diabetes.ACE2 and diabetes: ACE of ACEs?Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury.Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.ACE and ACE2 in kidney disease New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Angiotensin-converting enzyme 2: the first decade.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.Rat Ace allele variation determines susceptibility to AngII-induced renal damage Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2 Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity.Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy

P2860

Q27308039-66241EDD-A498-4F71-BC81-25F1A7F080A3 Q28387627-883C3F2C-4953-446E-A097-82E2B24D90D8 Q28538745-700C972A-3CBC-4F9A-8FFB-84FC9EEAFB21 Q28569684-0B38FB82-798A-456B-AF46-A367B799F152 Q30600509-1BB73EFD-2ACD-4521-A9FC-35B218AD8797 Q33795353-67346BEB-FE3D-447E-ACAC-5D7B02C30CA9 Q33800185-25C87743-7ACB-4172-B6FF-7EF080A4C206 Q34065655-E6A54297-9B25-407B-B2B3-D635D7E97B2E Q34277437-83BF4FC2-08B4-4F60-B49D-777622827D1C Q34282114-B36128FA-1D14-4938-9D58-AD10FF0ABD59 Q34293723-4C19BDF8-9A51-45EB-ADC6-9D682A76BACC Q34302600-10671DB4-AA86-43FD-8542-F0D17401B87F Q34319638-7673F389-2B9E-4D6F-A0E6-3E5C4AA9983F Q34355126-993CF6AD-06AF-499B-B265-3B6CB8742507 Q34500735-0FEF4C9C-8DF6-4320-A7DE-E9BEAD010085 Q34580630-B79C5405-18BD-4866-A94C-D37FBF319C42 Q34784864-516938F9-03DE-437C-99E3-7FE2FF8789F7 Q34866649-EDC010E8-7053-45BC-A2F5-F673CA94F82A Q34892110-EF331940-E560-4A85-A0BA-185612F32FC1 Q34949521-B6D58108-8B0E-4707-A68B-EB8ECB142A74 Q35050508-9EC8F92F-7B96-4D6D-8A58-F70A1BB8CF28 Q35050821-2D503554-87FA-4EEC-B5C1-FF78786A9A42 Q35137270-F0285914-68E5-4005-854A-ECC32A39FF76 Q35152116-54C2A7C6-B853-4B32-A3E3-086A6997475E Q35192530-A1BED533-02C1-4857-AE59-0FD4A510C4CF Q35550937-F37AF43E-39E5-4731-945E-65EE0D9C2852 Q35760437-B1D34608-8C1D-4F0A-A143-E3DF7834FCBF Q35923732-3F42D5A8-A475-473A-B024-30BFD5E73E7F Q35924552-AE300CA0-ABC6-4846-8D83-B0B9C39ACA18 Q35974821-E5D67E2C-C055-4251-B05E-CBFE95AA54D6 Q36020040-BA4AF64E-DC2F-4B40-9958-63BF3A7748D4 Q36024889-29462E79-49B2-48AF-A379-351E0864B375 Q36042210-F52118EB-BFB6-4E33-AA93-A6A261EF7BEB Q36087047-D0A629FA-2D85-4C74-BC6F-46B0F079C9A0 Q36104801-57196B58-2FF2-4F95-B7F1-0FD08CC143BD Q36116045-F2BCC0F3-9670-42A5-B141-F90E89628BBC Q36392875-F7FFEBCF-0F61-4E5E-9BF8-B51FA789FA1F Q36473779-6E6DC5EB-31AA-4971-8789-0E1BFF94A450 Q36477252-434EAE3D-6024-4FE8-AEEE-EF94AEF606CD Q36605186-1503CBE9-17BD-4BAF-9555-516D1B1CBD43

P2860

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

http://www.wikidata.org/entity/Q41786103

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

@en

type

label

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

@en

prefLabel

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

@en

P1433

Q41786103-434C9040-4F5A-435F-8BD1-585421D93916

P1476

Q41786103-56B3D752-EB31-4BA9-968B-5FB6EB9850EC

P2093

Q41786103-01B7C1CB-227D-4EA2-A25F-64CB4F992955

Q41786103-143D0549-78C0-4619-B402-87F238821666

Q41786103-2B1C00D8-9CBC-4514-A2A0-79C45E4C509A

Q41786103-320F4925-E4CD-4019-9201-448CA475A986

Q41786103-36AD95A6-A349-4983-9166-F7ABEEA94D52

Q41786103-3A9C5EAF-FF13-4873-8250-B8F62721C508

Q41786103-68ED7143-A1DB-4143-BF7E-C848C4AC334A

Q41786103-75FAE79C-5986-4DCA-A738-F1EACA5DA79F

Q41786103-985B20B3-F991-4B60-A7F2-823B4717A935

Q41786103-C8D71FC6-C57C-4447-9970-1BA716BBAA9C

P2860

Q41786103-033D46AA-BD76-49DE-AD00-2054B0F8E4FF

Q41786103-087CAECF-1DD8-4CDA-B155-1F58A744141F

Q41786103-0CA4CB24-68F6-4753-AC38-6046B4AF2044

Q41786103-0CD6920E-230D-4AF6-BE66-76D7A044CA61

Q41786103-1383798C-D884-4802-8DD8-802E24ACC8C6

Q41786103-14E99008-1284-4257-894D-493BCBF13EE7

Q41786103-1B6120E2-44C4-4A6F-B325-999CD30BD34B

Q41786103-206772A4-CF59-4604-9026-99559EAF4D50

Q41786103-248E94A2-9AEB-418E-A857-5FD4C65D06C0

Q41786103-26A61149-8479-4E5F-95EC-F376F6B021E3

P304

Q41786103-FF938C61-3059-4263-81AA-161766FD2B87

P31

Q41786103-38071EDF-862B-486D-8D75-852444DD1D04

P356

Q41786103-59E3D150-9ED6-4F2F-8E2D-CEC1033B850A

P407

Q41786103-20502DF8-F23B-428A-AEDA-BBED3846027D

P433

Q41786103-7D12DEC7-E874-4612-962C-2ABC358CA472

P478

Q41786103-07D46EB5-DC33-441D-B9F2-5CA479632CCE

P50

Q41786103-B0BC91B9-1BD0-4C9E-A286-ABDDB627FFCA

P577

Q41786103-D192613C-B3DF-402B-8581-45BB6F9E9A9A

P5875

Q41786103-7416A6C8-7449-4CBA-915A-407D46CF85D3

P698

Q41786103-C70026CB-72B4-4FAB-B99F-567AFD8269C6

P932

Q41786103-84CCAA9A-65DC-49DF-9FF0-822F8ED61C40

P356

P1433

P1476

Human recombinant ACE2 reduces the progression of diabetic nephropathy.

@en

P2093

Andrew M Herzenberg

http://www.w3.org/2001/XMLSchema#string

Evelyne Janzek

http://www.w3.org/2001/XMLSchema#string

Fung L Chow

http://www.w3.org/2001/XMLSchema#string

Gavin Y Oudit

http://www.w3.org/2001/XMLSchema#string

George C Liu

http://www.w3.org/2001/XMLSchema#string

Hans Loibner

http://www.w3.org/2001/XMLSchema#string

James W Scholey

http://www.w3.org/2001/XMLSchema#string

Jiuchang Zhong

http://www.w3.org/2001/XMLSchema#string

Joyce Zhou

http://www.w3.org/2001/XMLSchema#string

Manfred Schuster

http://www.w3.org/2001/XMLSchema#string

P2860

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

ACE2: from vasopeptidase to SARS virus receptor

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

Prevalence of chronic kidney disease in the United States

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

The intrarenal renin-angiotensin system and diabetic nephropathy.

P304

529-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-1218

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

P577

2009-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40027356

http://www.w3.org/2001/XMLSchema#string

P698

19934006

http://www.w3.org/2001/XMLSchema#string

P932

2809962

http://www.w3.org/2001/XMLSchema#string